Recently, transcriptomic analysis of urinary EVs from PCa patients has been carried out with promising results for Cadherin 3, which shows a decreased abundance in PCa samples as a source of biomarkers [27] and the use of microRNAs as markers for this disease has also been extensively reported [28]. Here, CDH3 is linked to posterior cortical atrophy.